Methylcobalamin vs Cyanocobalamin: Is Methyl B12 Worth the Premium?

Shop for vitamin B12 and you will be steered toward methylcobalamin, the "active" or "natural" form, and away from cyanocobalamin, the common form with "cyanide" in its name. The pitch is that methyl B12 is ready to use, better absorbed, better retained and safer. It sounds sensible. The research tells a different story.

We found no well-designed trial comparing methylcobalamin with cyanocobalamin on a health outcome, and the body processes both the same way before using them. This guide covers how B12 is absorbed and used, where the methyl claims come from, the cyanide question, the few situations where form may matter, and what each form costs. One surprise: methyl B12 is not always the expensive option.

The forms in a nutshell

Vitamin B12 is a large molecule built around a cobalt atom, with one small group attached on top. That group gives each form its name. Cyanocobalamin carries a cyanide group, methylcobalamin a methyl group, adenosylcobalamin an adenosyl group, and hydroxocobalamin a hydroxyl group. NIH notes that cyanocobalamin is the most common form in supplements.

Methylcobalamin and adenosylcobalamin are the two forms the body actually uses as enzyme helpers, which is why methyl is marketed as "active." Cyanocobalamin and hydroxocobalamin become active once the body converts them. As the next sections show, the body converts the methyl form too.

The evidence at a glance

These summaries describe research. They are not claims about what a supplement does. People with reduced kidney function, a hereditary optic nerve condition, or symptoms such as numbness or tingling should talk with a clinician before choosing a B12 product.

What your cells do with each form

Inside the cell, a processing protein called MMACHC removes the upper group from whatever B12 arrives: it takes the cyanide off cyanocobalamin and the methyl off methylcobalamin, leaving the same core molecule. The cell then attaches new groups itself to make the two working forms, methylcobalamin and adenosylcobalamin. Laboratory work from Ruma Banerjee's group described this step, and a 2015 review by Danish and German researchers called it obligatory before the cell makes its own working forms.

That is the core problem with the "active form" pitch. The methyl group you swallow is not the one your enzymes use; the cell supplies its own, mainly from folate. Even a 2017 review favoring the "natural" forms states that the methyl and adenosyl groups from supplements "are cleaved inside cells and are not used" to make the cell's own active B12, yet it still concluded those forms are preferable. The paper lists its second author as chief medical officer of a practitioner supplement company. The 2015 review concluded that methyl and adenosyl forms are unlikely to be better than cyanocobalamin, and that cyanocobalamin's stability and low cost make it well suited for oral supplements.

One nuance: hydroxocobalamin may partly bypass that processing step, one reason injected hydroxocobalamin is used for rare inherited disorders of B12 processing; the 2015 review judged this unlikely to matter when processing works normally. Those are treated by specialists, not with store-bought methyl B12.

Absorption: dose matters, form does not

B12 is absorbed mainly with the help of intrinsic factor, a protein made in the stomach. That system handles only about 1.5 to 2 mcg at a time. Above that, a small share passes through the gut wall by diffusion. NIH puts absorption at about 50 percent for doses under 1 to 2 mcg, about 2 percent at 500 mcg and about 1.3 percent at 1,000 mcg, and states that no evidence indicates absorption from supplements varies by form.

This is why high oral doses can still raise blood B12 even when intrinsic factor is missing. A 2018 Cochrane review of three trials found that 1,000 to 2,000 mcg a day by mouth normalized blood B12 about as well as injections in people with deficiency, though it rated the evidence low quality. One of those trials used 2,000 mcg of cyanocobalamin a day. Sublingual tablets, dissolved under the tongue, performed no better than swallowed ones in trials; NIH says the evidence suggests no difference between them.

The human head-to-head data on form are thin. In a 2021 survey of 42 Romanian vegans, people taking cyanocobalamin had higher holotranscobalamin, a marker of active B12 in the blood, than those taking methylcobalamin (median 150 vs 78.5 pmol/L), even though the methyl group took larger doses on average (988 vs 582 mcg per dose, a difference that was not statistically significant). The authors reported better results with cyanocobalamin, but this was a small survey of 21 cyanocobalamin and 14 methylcobalamin users, not a trial, and it cannot show cause. A review of 158 young children's records found sublingual methylcobalamin raised B12 about as well as oral or injected cyanocobalamin. A small 1971 study that gave people tiny labeled doses (1 to 25 mcg) of four forms found no consistent difference in how much was retained. The only randomized comparison we found was a preliminary 1996 study of 20 healthy adults given 3 mg a day of either form for two weeks; it reported shorter sleep and some alertness changes with methyl, but it was tiny, short and has not been repeated.

Methyl B12 does have good trial evidence for raising low B12: in a 6-month trial of 50 people with low B12 after gastric bypass surgery, 1,000 mcg a day of oral methylcobalamin normalized B12 as well as hydroxocobalamin injections. That trial did not include cyanocobalamin, so it shows methyl works, not that it works better.

The retention claim and where it comes from

A common selling point is that cyanocobalamin is "excreted three times more in urine" while methylcobalamin is better stored. That figure traces to a 1973 study by Okuda and colleagues. The 2017 review most often cited for it describes that study as an animal study; it reported similar blood absorption for the two forms, with more cyanocobalamin in urine and slightly more storage in the liver with methyl. Some later papers repeat the urine figure without saying it came from an animal study. We could not find it confirmed in humans at supplement doses.

The better-documented retention difference is between cyanocobalamin and hydroxocobalamin injections: injected hydroxocobalamin stays in the body longer, which is why it can be injected less often. That is about injection schedules, not about methyl tablets.

The cyanide question

The word "cyano" scares people, so here is the arithmetic. The cyanide group makes up about 1.9 percent of the cyanocobalamin molecule by weight, so a 1,000 mcg tablet contains about 19 mcg of cyanide. Only about 1.3 percent of that dose is absorbed, and the cyanide is tightly bound to the vitamin, so the cyanide entering the body is likely well under 1 microgram; we found no study measuring it directly. Even if all 19 mcg were absorbed, it would be under 2 percent of the limit below. For scale, the European Food Safety Authority set a short-term (single-day) safe intake for cyanide of 20 mcg per kilogram of body weight, about 1,400 mcg for a 70 kg adult. EFSA could not set a long-term limit for cyanide because the data were too limited, so we cannot give a formal long-term safety margin. We found no health agency stating that the cyanide in B12 supplements is harmful at supplement doses.

There is an irony here: hydroxocobalamin is the antidote for cyanide poisoning precisely because it grabs cyanide and turns into cyanocobalamin, which the kidneys then excrete.

When form may matter

Reduced kidney function. In the DIVINe trial, published in 2010, 238 people with diabetes and kidney damage took folic acid, vitamin B6 and 1,000 mcg of cyanocobalamin a day, or placebo, for about three years. Kidney function declined faster, and a combined count of heart attacks, strokes, artery-opening procedures and deaths was about twice as common on the vitamins. A later review noted that all the events occurred in people with an estimated kidney filtration rate (eGFR) below 50, a sign of moderately reduced kidney function.

One of the trial's investigators has argued that cyanide from cyanocobalamin may build up when the kidneys are weak and has recommended methylcobalamin or hydroxocobalamin instead, and the 2018 review made the same suggestion for people with impaired kidney function. That is a reasonable precaution but not a proven cause: the trial gave three vitamins at high doses together, we found no trial comparing methyl with cyanocobalamin in kidney disease, and a small 2026 trial in people with diabetic nerve damage reported a decline in estimated kidney function with 2,000 mcg a day of methylcobalamin, though it had no placebo group. If you have kidney disease, ask your clinician about both the form and the dose.

Leber hereditary optic neuropathy. The US label for cyanocobalamin injection warns that people with early Leber's disease, an inherited optic nerve condition, suffered severe and rapid optic nerve damage when treated with cyanocobalamin. The alternative that the National Academies' 1998 B12 report points to is hydroxocobalamin. This is a rare condition; if it runs in your family, ask a specialist which form to use.

Rare inherited B12 processing disorders. These are treated with injected hydroxocobalamin under specialist care. Methylcobalamin has not been well tested in that setting.

Notice that none of these exceptions point to methyl B12 as the obvious answer for the general public; two point to hydroxocobalamin.

Methylation, MTHFR and nerve claims

MTHFR. Methyl B12 is often sold to people with a common MTHFR gene variant. MTHFR works on the folate side of the pathway, and the methyl group from swallowed methylcobalamin is removed anyway. We found no trial testing B12 form by MTHFR genotype; the only trial we found that grouped people by these gene variants gave a methylfolate, P5P and methylcobalamin product, supplied by its maker, against placebo rather than cyanocobalamin. Other trials of methyl B12 plus methylfolate combinations also used placebo or no treatment as the comparison. Our folate vs folic acid guide covers the folate side of that debate.

Nerve health. Much of the methylcobalamin nerve research comes from Japanese and other Asian practice, often using injected or very high doses, and we found none that compares methyl with cyanocobalamin. A 2020 meta-analysis of 15 trials judged most to be at high risk of bias and found no effect on pain or symptom scores, though it reported better overall response ratings than other active treatments. One well-run trial is useful here: in 90 people on long-term metformin with nerve damage and low or low-normal B12 (below 400 pmol/L), 1,000 mcg a day of oral methylcobalamin improved nerve measures compared with placebo. That trial tested raising low B12 against a placebo; it does not show methyl beats cyano.

Energy. We found no good evidence that methylcobalamin improves energy or "methylation" in people who are not low in B12; the tiny 1996 study reported an alerting effect in healthy adults that has not been confirmed. NIH notes that B12 supplements do not appear to improve performance or endurance when B12 status is adequate.

Stability on the shelf

Cyanocobalamin is the most stable form of B12. Methylcobalamin is sensitive to light and breaks down faster in acidic conditions or when mixed with vitamin C: in one laboratory study it lost 70 to 76 percent with vitamin C, while cyanocobalamin was the most stable of the forms tested. Exposed to ultraviolet light in solution, methyl and adenosyl forms convert to hydroxocobalamin within seconds. A small 2025 lab test of 10 supplements found five of six methylcobalamin products below their label amounts, two at about 40 percent, while two of four cyanocobalamin products were also below label. The authors did not attribute the shortfalls to breakdown, tested one batch of each, and the products were not identified as US brands. If you buy methyl B12, store it in an opaque container away from light and heat.

Label math and cost

Compare products at the same dose, since absorption falls as the dose rises. Here is what 1,000 mcg products cost on October 31, 2026, from retailer and brand listings. Prices change, and some listings reflected a sale.

Prices from Walmart, iHerb and brand listings, read October 31, 2026; the iHerb listings showed an October sale. Price per 1,000 mcg is our arithmetic.

The cheapest methyl product we priced cost about the same per tablet as Nature Made cyanocobalamin, and Costco's Kirkland 5,000 mcg quick-dissolve tablet is methylcobalamin too. The real premium is brand: Thorne's methylcobalamin cost about five to seven times as much per tablet as the store-brand and Nature Made cyanocobalamin products. Some product pages claim the body uses methylcobalamin "more efficiently"; we found no clinical evidence for that.

Which one should you choose?

Start with whether you need a supplement. The adult recommended dietary allowance (RDA) is 2.4 mcg a day, and most people who eat animal foods get enough. NIH and the National Academies advise adults over 50 to get most of their B12 from fortified foods or supplements, because many older adults absorb B12 from food poorly. Vegans need a reliable source of B12 from supplements or fortified foods.

For most people: pick the dose and delivery you like at a fair price. A daily 1,000 mcg tablet of either form is a common choice for people at risk of running low; lower doses taken daily, or larger weekly doses, are also used. Cyanocobalamin is the most studied and most stable, and usually among the cheapest. Methylcobalamin is a fine choice if you prefer it, as long as you are not paying a large premium for it. To check the form, look at the Supplement Facts line, which reads "Vitamin B12 (as cyanocobalamin)" or "(as methylcobalamin)." Combination products with methyl plus adenosyl forms face the same issue: both groups are removed inside the cell, and we found no trial showing the combination works better.

If you have kidney disease or a family history of Leber hereditary optic neuropathy: ask your clinician which form and dose to use. Methylcobalamin or hydroxocobalamin may be suggested.

If you smoke: the National Academies note that the cyanide in cigarette smoke may disturb B12 metabolism, though they judged its effect on B12 needs to be negligible. We found no trial testing whether the supplement form matters for smokers.

For product picks, see our B12 supplement rankings, and for symptoms of low B12, see our B12 deficiency guide.

Who should test, and safety

Frequently asked questions

Is methylcobalamin better than cyanocobalamin?

Not for most people. NIH finds no evidence that absorption differs by form, and inside the cell the methyl group is removed before the cell builds its own active B12. The only randomized comparison we found was a tiny two-week 1996 study in healthy adults, too small to show that either form is better. Cyanocobalamin is the most studied and most stable form; methylcobalamin is a reasonable alternative but not a superior one.

Is the cyanide in cyanocobalamin dangerous?

Not at supplement doses, as far as we found. By our arithmetic a 1,000 mcg tablet contains about 19 mcg of cyanide, and only about 1.3 percent of that dose is absorbed. That is far below the European Food Safety Authority's short-term safe intake of about 1,400 mcg for a 70 kg adult. EFSA has not set a long-term limit for cyanide, so no formal long-term margin exists. People with kidney disease should ask their clinician about form and dose.

Is methyl B12 better absorbed or retained?

We found no human evidence that it is at supplement doses. A small 1971 human study at very low doses found no consistent difference between forms. The claim that cyanocobalamin is excreted three times more in urine comes from a 1973 study described as an animal study. In a small survey of vegans, those taking cyanocobalamin actually had higher active B12 in their blood, though a survey like this cannot show cause.

Who should avoid cyanocobalamin?

People with Leber hereditary optic neuropathy, a rare inherited eye condition, because the injection label warns of optic nerve damage; the National Academies point to hydroxocobalamin instead. People with reduced kidney function should ask a clinician, since a trial of high-dose B vitamins including cyanocobalamin found faster kidney decline, though the cause is not proven.

Is sublingual B12 better than a regular tablet?

No. Trials found sublingual tablets, dissolved under the tongue, raised B12 about as well as swallowed tablets, and NIH says the evidence suggests no difference. High oral doses of 1,000 to 2,000 mcg a day also raised blood B12 about as well as injections in a Cochrane review, though the evidence was low quality.

How much B12 should you take?

The adult recommended dietary allowance (RDA) is 2.4 mcg a day. Because only about 1.3 percent of a 1,000 mcg dose is absorbed, single-nutrient supplements usually contain 500 to 1,000 mcg. No upper limit has been set. If you are at risk of running low (for example, with long-term metformin use) or have symptoms such as numbness or tingling, get tested rather than guessing.

The bottom line

Methylcobalamin is a perfectly good form of B12, but it is not a better one for most people. Your cells strip the methyl group off and rebuild their own active B12, NIH finds no evidence that absorption differs by form, and the "better retained" claim traces to a 1973 study described as an animal study. Cyanocobalamin is the most studied and most stable form, and the cyanide it contains is a trivial amount.

Choose by dose, price and how you like to take it. If methyl B12 costs the same, buy it if you prefer it; if it costs five times as much, the extra money buys a brand, not a better vitamin. Get tested if you are at risk of running low (older adults, vegans, long-term metformin or acid-reducer users) or have numbness, tingling or unusual tiredness, and ask a clinician about form and dose if you have kidney disease or Leber hereditary optic neuropathy.